|

Cisplatin injection Clinical Trials

11 actively recruiting trials across 1 location

No change since May 2026

Also known as: Cisplatin, Platinum - Etoposide, carboplatin injection

Pipeline

Phase 2: 6Phase 3: 3Phase 1/2: 2

Top Sponsors

  • Suzhou Suncadia Biopharmaceuticals Co., Ltd.2
  • Shanghai Hengrui Pharmaceutical Co., Ltd.2
  • Nanjing Leads Biolabs Co.,Ltd2
  • University of Missouri-Columbia1
  • Shanghai Shengdi Pharmaceutical Co., Ltd1

Indications

  • Cancer11
  • Advanced Solid Tumour2
  • Advanced Cervical Cancer1
  • Cancer of the Head and Neck1
  • Recurrent or Metastatic Cervical Cancer1

Other10 trials

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
Phase 2
A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]
Phase 2
A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer
Phase 3
A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)
Phase 3
A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors
Phase 2
A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer
Phase 1/2
Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy
Phase 3
Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary
Phase 2
Dose Escalation Using Hypoxia-adjusted Radiotherapy
Phase 2
SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer
Phase 1/2

Columbia, Missouri1 trial

Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer

University of Missouri

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.